Pdt Partners, LLC Acadia Pharmaceuticals Inc Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Pdt Partners, LLC holds 13,218 shares of ACAD stock, worth $259,072. This represents 0.02% of its overall portfolio holdings.

Number of Shares

13,218

Holding current value

$259,072

% of portfolio

0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $200,120 - $252,992	13,218 New	13,218 $203,000
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $564,384 - $862,873	-27,160 Reduced 66.64%	13,599 $425,000
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $1.18 Million - $1.9 Million	-56,746 Reduced 58.2%	40,759 $849,000
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $1.24 Million - $1.78 Million	-69,490 Reduced 41.61%	97,505 $2.34 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $2.24 Million - $2.87 Million	137,309 Added 462.54%	166,995 $3.14 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $90,880 - $119,232	6,400 Added 27.48%	29,686 $472,000
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $899,117 - $1.16 Million	-63,722 Reduced 73.24%	23,286 $381,000
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $2.05 Million - $4.3 Million	-157,817 Reduced 64.46%	87,008 $1.23 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $1.17 Million - $1.53 Million	55,697 Added 29.45%	244,825 $5.93 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $570,893 - $921,114	-34,002 Reduced 15.24%	189,128 $4.41 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $2.73 Million - $4.29 Million	173,130 Added 346.26%	223,130 $3.71 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $969,999 - $1.37 Million	50,000 New	50,000 $1.22 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $7.34 Million - $11.7 Million	-512,358 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $2.2 Million - $3.69 Million	-169,142 Reduced 24.82%	512,358 $10.6 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $1.07 Million - $1.58 Million	70,800 Added 11.59%	681,500 $10.4 Million
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $13.7 Million - $19.7 Million	610,700 New	610,700 $13.7 Million

Others Institutions Holding ACAD

# of Institutions

284

Shares Held

158M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.17B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account